Evonik's earnings, sales beat consensus, expects growth in specialties during 2020

18:08 PM | March 4, 2020 | Mark Thomas

Adjusted earnings rise 38% YOY for fourth quarter; estimates €30-million financial impact due to COVID-19 outbreak for the first quarter of 2020.